July 27, 2014 | The Israeli company BrainStorm Cell Therapeutics is expected to receive a $5 million grant from the Brazilian Ministry of Health. The funds will go towards conducting trials on its product in conjunction with the University of Sao Paolo, according to “Globes.” The company has yet to respond to the reports, which are not yet official. BrainStorm Cell Therapeutics specializes in developing stem cell therapies for the treatment of neurodegenerative diseases such as ALS (Lou Gehrig’s disease), multiple sclerosis, and Parkinson’s disease.
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts
Water Management Pioneer Unveils Unique New Anti-Leak Platform
October 06, 2024
Israel Sending 20 Green Tech Firms To UN Climate Conference
October 06, 2024
Tel Aviv University Ranked 7th In World For Global Entrepreneurship
October 01, 2024
Facebook comments